Special sugar, nanoparticles combine to detect cholera toxin
A complex sugar may someday become one of the most effective weapons to stop the spread of cholera, a disease that has claimed thousands of lives in Haiti since the devastating earthquake last year.
A technique developed by University of Central Florida scientists would allow relief workers to test water sources that could be contaminated with the cholera toxin. In the test, the sugar dextran is coated onto iron oxide nanoparticles and then added to a sample of the water. If the cholera toxin is present, the toxin will bind to the nanoparticles' dextran. This is because dextran looks similar to the cholera toxin receptor (GM1) found on cells' surface in the victim's gut.
The technique likely would be less expensive than those currently available, and it would provide results more quickly, enabling workers to restrict access to contaminated sources and limit the spread of the disease.
"It's really quite amazing," said UCF assistant professor J. Manuel Perez, the lead researcher on the project. "It means we have a quicker diagnostic tool using a simple and relatively cheap sugar-nanoparticle combination."
Early studies also show that the technique could someday be used to treat someone infected with cholera, which is caused by poor sanitation and dirty water, and potentially other diseases, Perez said.
More studies are needed to prove the adaptability of the technique, but its impact could be huge. In countries with poor sanitation, outbreaks caused by drinking contaminated water often prove fatal. Deadly toxins also can result from bioterrorism or food contamination.
Dr. Perez works in his lab.
Most read news
Other news from the department science
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Predicting the mode of action of new anti-cancer drugs with AI - Acceleration of the development of new cancer drugs
Chemists develop MRI-like technique to detect what ails batteries
New corona mass test up to 100 times more sensitive than rapid antigen tests - The innovative corona test "LAMP-Seq"
A more complete picture of the nano world
Nimbus Discovery and Proteros enter into multi-target X-ray protein crystallography collaboration
Lab901 and Biofortuna to collaborate on automated PCR Dx for HLA and Coeliac disease
Mode of action of the vaccine adjuvant flagellin in fusion proteins has been clarified
Alternative methods replace animal experiments: 20 years successful work by ZEBET within BfR - ZEBET celebrates its anniversary with an international symposium at BfR in Berlin
Imaging the smallest atoms provides insights into an enzyme's unusual biochemistry - This could help in the design of enzymes for the chemical industry